Medication adherence and hospital readmissions: A cross-sectional analysis of Medicare Star Ratings performance

IF 2.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY
Eric P. Borrelli, Nathan E. Barnes, Peter Saad, Kristie Dooley, Heather Nelkin, Idal Beer, Julia D. Lucaci
{"title":"Medication adherence and hospital readmissions: A cross-sectional analysis of Medicare Star Ratings performance","authors":"Eric P. Borrelli,&nbsp;Nathan E. Barnes,&nbsp;Peter Saad,&nbsp;Kristie Dooley,&nbsp;Heather Nelkin,&nbsp;Idal Beer,&nbsp;Julia D. Lucaci","doi":"10.1016/j.japh.2025.102911","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The Medicare Star Ratings program, administered by the Centers for Medicare &amp; Medicaid Services, includes a list of quality measures aimed at evaluating the quality of care provided by Medicare health plans. These measures include 3 medication adherence measures (non-insulin antidiabetics, renin-angiotensin system antagonists (RASA), and statins), as well as a plan all-cause readmission (PACR) measure, among dozens of other measures.</div></div><div><h3>Objective</h3><div>To examine the potential association between the 3 Medicare Star Rating medication adherence measures and the PACR measure.</div></div><div><h3>Methods</h3><div>An analysis of the publicly available annual health plan Medicare Star Rating performance data were conducted for the Star Rating years of 2015–2024, except years 2021–2023 when the PACR measure was not assessed by CMS. The primary outcomes were odds ratios (ORs) and 95% confidence intervals (CIs) evaluating the likelihood of a health plan achieving ≥4-stars on the PACR measure if it also earned ≥4-stars or 5-stars on the adherence measure(s).</div></div><div><h3>Results</h3><div>Health plans that achieved ≥4-stars or 5-stars on the RASA measure had significantly higher odds of achieving ≥4-stars on the PACR measure (OR:1.53, 95% CI:1.30–1.81; OR:1.51, 95% CI:1.26–1.81; respectively), as did plans that achieved ≥4-stars or 5-stars on the statin adherence measure (OR: 1.58, 95% CI:1.31–1.86; OR:1.94, 95% CI: 1.55–2.43; respectively). There was no significant impact for the diabetes adherence measure (≥4-stars OR: 1.10, 95% CI:0.93–1.30; 5-stars OR: 1.09, 95% CI: 0.89–1.33). The likelihood of achieving ≥4-stars on the PACR measure increased non-significantly with the number of adherence measures that achieved 5-stars (all 3 adherence measures OR: 1.53, 95% CI: 1.17–2.00; only 2 adherence measures OR: 1.44, 95% CI: 1.09–1.90; only 1 adherence measure OR: 1.11, 95% CI: 0.87–1.41).</div></div><div><h3>Conclusion</h3><div>Health plans with higher performance on the Medicare Star Ratings adherence measures had significantly increased odds of high performance on the Medicare Star Ratings PACR measure, suggesting an association between effective medication management and reduced all-cause readmissions.</div></div>","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":"65 6","pages":"Article 102911"},"PeriodicalIF":2.5000,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Pharmacists Association","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1544319125005904","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

The Medicare Star Ratings program, administered by the Centers for Medicare & Medicaid Services, includes a list of quality measures aimed at evaluating the quality of care provided by Medicare health plans. These measures include 3 medication adherence measures (non-insulin antidiabetics, renin-angiotensin system antagonists (RASA), and statins), as well as a plan all-cause readmission (PACR) measure, among dozens of other measures.

Objective

To examine the potential association between the 3 Medicare Star Rating medication adherence measures and the PACR measure.

Methods

An analysis of the publicly available annual health plan Medicare Star Rating performance data were conducted for the Star Rating years of 2015–2024, except years 2021–2023 when the PACR measure was not assessed by CMS. The primary outcomes were odds ratios (ORs) and 95% confidence intervals (CIs) evaluating the likelihood of a health plan achieving ≥4-stars on the PACR measure if it also earned ≥4-stars or 5-stars on the adherence measure(s).

Results

Health plans that achieved ≥4-stars or 5-stars on the RASA measure had significantly higher odds of achieving ≥4-stars on the PACR measure (OR:1.53, 95% CI:1.30–1.81; OR:1.51, 95% CI:1.26–1.81; respectively), as did plans that achieved ≥4-stars or 5-stars on the statin adherence measure (OR: 1.58, 95% CI:1.31–1.86; OR:1.94, 95% CI: 1.55–2.43; respectively). There was no significant impact for the diabetes adherence measure (≥4-stars OR: 1.10, 95% CI:0.93–1.30; 5-stars OR: 1.09, 95% CI: 0.89–1.33). The likelihood of achieving ≥4-stars on the PACR measure increased non-significantly with the number of adherence measures that achieved 5-stars (all 3 adherence measures OR: 1.53, 95% CI: 1.17–2.00; only 2 adherence measures OR: 1.44, 95% CI: 1.09–1.90; only 1 adherence measure OR: 1.11, 95% CI: 0.87–1.41).

Conclusion

Health plans with higher performance on the Medicare Star Ratings adherence measures had significantly increased odds of high performance on the Medicare Star Ratings PACR measure, suggesting an association between effective medication management and reduced all-cause readmissions.
药物依从性和医院再入院:医疗保险星级评分表现的横断面分析。
背景:医疗保险星级评定项目,由医疗保险和医疗补助服务中心管理,包括一系列旨在评估医疗保险健康计划提供的护理质量的质量措施。这些措施包括三种药物依从性措施(非胰岛素降糖药,肾素-血管紧张素系统拮抗剂(RASA)和他汀类药物),以及计划全因再入院(PACR)措施,以及数十种其他措施。目的:探讨三种医疗星级药物依从性测量与PACR测量之间的潜在关联。方法:分析2015-2024年公开的年度健康计划Medicare Star Rating绩效数据,除2021-2023年未评估PACR措施外。主要结局是比值比(OR)和95%置信区间(CI),如果健康计划在PACR测量中也获得≥4星或≥5星的依从性测量,则评估该健康计划在PACR测量中获得≥4星的可能性。结果:在RASA测量中达到≥4星或5星的健康计划在PACR测量中达到≥4星的几率显著更高(or:1.53, 95% CI:1.30-1.81; or:1.51, 95% CI:1.26-1.81;分别),在他汀类药物依从性测量中达到≥4星或5星的计划也是如此(or:1.58, 95% CI:1.31-1.86; or:1.94, 95% CI:1.55-2.43;分别)。糖尿病依从性测量没有显著影响(≥4星OR:1.10, 95% CI:0.93-1.30;≥5星OR:1.09, 95% CI:0.89-1.33)。达到PACR≥4星的可能性随着达到5星的依从性措施的数量而增加(所有3个依从性措施OR:1.53, 95% CI:1.17-2.00;只有2个依从性措施OR:1.44, 95% CI:1.09-1.90;只有1个依从性措施OR:1.11, 95% CI:0.87-1.41)。结论:在医疗保健星级评分依从性措施上表现较好的健康计划在医疗保健星级评分PACR措施上表现优异的几率显著增加,表明有效的药物管理与减少全因再入院之间存在关联。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.30
自引率
14.30%
发文量
336
审稿时长
46 days
期刊介绍: The Journal of the American Pharmacists Association is the official peer-reviewed journal of the American Pharmacists Association (APhA), providing information on pharmaceutical care, drug therapy, diseases and other health issues, trends in pharmacy practice and therapeutics, informed opinion, and original research. JAPhA publishes original research, reviews, experiences, and opinion articles that link science to contemporary pharmacy practice to improve patient care.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信